Emergence of the less common cannabinoid Δ


Journal

Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449

Informations de publication

Date de publication:
Nov 2021
Historique:
revised: 28 08 2021
received: 14 07 2021
accepted: 31 08 2021
pubmed: 9 9 2021
medline: 17 3 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

Δ

Identifiants

pubmed: 34494719
doi: 10.1002/dta.3159
doi:

Substances chimiques

delta-8-tetrahydrocannabinol 5957-75-5
Dronabinol 7J8897W37S

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1936-1943

Subventions

Organisme : Ministry of the Interior

Informations de copyright

© 2021 John Wiley & Sons, Ltd.

Références

Patel B, Wene D, Fan Z. Qualitative and quantitative measurement of cannabinoids in cannabis using modified HPLC/DAD method. J Pharm Biomed Anal. 2017;146:15-23.
Webster GR, Sarna L, Mechoulam R. Conversion of CBD to delta8-THC and delta9-THC. US 2004/0143126 A1 2004.
Bow EW, Rimoldi JM. The structure-function relationships of classical cannabinoids: CB1/CB2 modulation. Perspect Medicin Chem. 2016;28(8):17-39.
Hollister LE, Gillespie HK. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration. Clin Pharmacol Ther. 1973;14(3):353-357.
Valiveti S, Hammell DC, Earles DC, Sinchcomb AL. LC-MS method for the estimation of Δ8-THC and 11-nor-Δ8-THC-9-COOH in plasma. J Pharm Biomed Anal. 2004;38:112-118.
Chan-Hosokawa A, Nguyen L, Lattanzio N, Adams WR. Emergence of delta-8 tetrahydrocannabinol in DUID investigation caseworks: Method development, validation and application. J Anal Toxicol. 2021;1-9. https://doi.org/10.1093/jat/bkab029
Villamor JL, Bermejo MJ, Taberno P, Fernández P, Sánchez I. GC/MS determination of 11-Nor-9-carboxy-Δ8-tetrahydrocannabinol in urine from cannabis users. Analytical Letters. 1998;31(15):2635-2643.
Harvey DJ, Brown NK. Comparative in vitro metabolism of the cannibinoids. Pharmacol Biochem Behav. 1991;40(3):533-540.
World Anti-Doping Agency, Prohibited List 2021. https://www.wada-ama.org/sites/default/files/resources/files/2021list_en.pdf. Accessed May 18, 2021.
World Anti-Doping Agency, Minimum required performance levels for detection and identification of non-threshold substances. https://www.wada-ama.org/sites/default/files/resources/files/td2019mrpl_eng.pdf. Accessed May 18, 2021.
World Anti-Doping Agency, Decision limits for the confirmatory quantification of exogenous threshold substances by chromatography-based analytical methods. https://www.wada-ama.org/sites/default/files/resources/files/td2021dl_final_eng_0.pdf. Accessed May 18, 2021.
Mareck U, Fusshöller G, Geyer H, Huestis MA, Scheiff AB, Thevis M. Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use. Drug Test Anal. 2021;13(3):539-549.
Thieme D, Rautenberg C, Grosse J, Schoenfelder M. Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: Suitability as a potential screening parameter in doping control. Drug Test Analysis. 2013;5(11-12):819-825.
World Anti-Doping Agency, International Standard 2021. https://www.wada-ama.org/sites/default/files/resources/files/isl_2021.pdf. Accessed April 28, 2021.
World Anti-Doping Agency, Minimum criteria for chromatographic-mass spectrometric confirmation of the identity of analytes for doping control purposes. https://www.wada-ama.org/sites/default/files/resources/files/td2021idcr_final_eng_0.pdf. Accessed April 28, 2021.
Bräuer P, Anielski P, Schwaiger S, et al. In vitro metabolism of selected bioactive compounds of Eurycoma longifolia root extract to identify suitable markers in doping control. Drug Test Anal. 2019;11(1):86-94.
Workbook Drug Market and Crime. https://www.dbdd.de/fileadmin/user_upload_dbdd/05_Publikationen/PDFs/REITOX_BERICHT_2020_DE_EN/WB_08_Drogenmaerkte_und_Kriminalitaet_2020.pdf. Accessed July 08, 2021.
Manno JE, Manno BR, Kemp PM, Alford DD, Abukhalaf IK, McWilliams ME. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-Nor- Δ9-tetrahydrocannabinol-9-carboxylic acid. J Anal Toxicol. 2001;25(7):538-549.

Auteurs

Sebastian Rzeppa (S)

Institute of Doping Analysis and Sport Biochemistry, Kreischa, Germany.

Joachim Große (J)

Institute of Doping Analysis and Sport Biochemistry, Kreischa, Germany.

Claudia Rautenberg (C)

Institute of Doping Analysis and Sport Biochemistry, Kreischa, Germany.

Detlef Thieme (D)

Institute of Doping Analysis and Sport Biochemistry, Kreischa, Germany.

Triin Lepp (T)

Estonian Center for Integrity in Sports, Tallinn, Estonia.

Henn Vallimäe (H)

Estonian Center for Integrity in Sports, Tallinn, Estonia.

Annekathrin M Keiler (AM)

Institute of Doping Analysis and Sport Biochemistry, Kreischa, Germany.
Environmental Monitoring and Endocrinology, Faculty of Biology, Technische Universität Dresden, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH